Keywords: strong, data, erbitux, flexible, dosing, german, drug

Strong data for Erbitux on flexible dosing

Article | 29 January 2007

Print This

German drug major Merck KGaA says that new data presented at the American Society of Clinical Oncology's gastro-intestinal meeting in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in